Online citations, reference lists, and bibliographies.

Development Of A Gold Nanoparticle-Based Lateral-Flow Immunoassay For Pneumocystis Pneumonia Serological Diagnosis At Point-of-Care

Ana Luísa Tomás, Miguel Peixoto de Almeida, Fernando Henríque Cardoso, Mafalda Pinto, Eulália Pereira, Ricardo Franco, Olga Matos
Published 2019 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Pneumocystis jirovecii pneumonia (PcP) is a major human immunodeficiency virus (HIV)-related illness, rising among immunocompromised non-HIV patients and in developing countries. Presently, the diagnosis requires respiratory specimens obtained through invasive and costly techniques that are difficult to perform in all patients or implement in all economic settings. Therefore, the development of a faster, cost-effective, non-invasive and field-friendly test to diagnose PcP would be a significant advance. In this study, recombinant synthetic antigens (RSA) of P. jirovecii’s major surface glycoprotein (Msg) and kexin-like serine protease (Kex1) were produced and purified. These RSA were applied as antigenic tools in immunoenzymatic assays for detection of specific anti-P. jirovecii antibodies (IgG and IgM) in sera of patients with (n = 48) and without (n = 28) PcP. Results showed that only IgM anti-P. jirovecii levels were significantly increased in patients with PcP compared with patients without P. jirovecii infection (p ≤ 0.001 with both RSA). Thus, two strip lateral flow immunoassays (LFIA), based on the detection of specific IgM anti-P. jirovecii antibodies in human sera samples, were developed using the innovative association of P. jirovecii’s RSA with spherical gold nanoparticles (AuNPs). For that, alkanethiol-functionalized spherical AuNPs with ca. ~40 nm in diameter were synthetized and conjugated with the two RSA (Msg or Kex1) produced. These AuNP-RSA conjugates were characterized by agarose gel electrophoresis (AGE) and optimized to improve their ability to interact specifically with serum IgM anti-P. jirovecii antibodies. Finally, two LFIA prototypes were developed and tested with pools of sera from patients with (positive sample) and without (negative sample) PcP. Both LFIA had the expected performance, namely, the presence of a test and control red colored lines with the positive sample, and only a control red colored line with the negative sample. These results provide valuable insights into the possibility of PcP serodiagnosis at point-of-care. The optimization, validation and implementation of this strip-based approach may help to reduce the high cost of medical diagnosis and subsequent treatment of PcP both in industrialized and low-income regions, helping to manage the disease all around the world.
This paper references
Serologic Responses to Pneumocystis Proteins in HIV Patients With and Without Pneumocystis jirovecii Pneumonia
Matthew R. Gingo (2011)
A serologic test to diagnose pneumocystis pneumonia: are we there yet?
Alison M. Morris (2011)
Nanogold based lateral flow assay for the detection of Salmonella typhi in environmental water samples
Jyoti Singh (2015)
Development of a colloidal gold-based lateral-flow immunoassay for the rapid simultaneous detection of zearalenone and deoxynivalenol
Anna Yu Kolosova (2007)
This is an Open Access article distribut...
“ Pneumocystis jirovecii and PcP , ”
K. Kon
Toxoplasma gondii: enzyme-linked immunosorbent assay based on a recombinant multi-epitope peptide for distinguishing recent from past infection in human sera.
Jian-fang Dai (2013)
Serologic responses to Pneumocystis proteins in human
A G (2011)
International HIV - associated opportunistic pneumonias ( IHOP ) study ; lung HIV study . HIV associated pneumocystis pneumonia
L. Huang (2011)
Enzyme-Linked Immunosorbent Assay and Serologic Responses to Pneumocystis jiroveci
Kieran R. Daly (2004)
A Single-Copy Gene Encodes Kex1, a Serine Endoprotease of Pneumocystis jiroveci
Geetha Kutty (2003)
Evaluation of a Recombinant Multiepitope Peptide for Serodiagnosis of Toxoplasma gondii Infection
Jianfang Dai (2012)
Detection of Antibodies Relevant to Infectious Disease
Steven W Binder (2013)
Current advances in laboratory diagnosis
A. L. Tomás (2018)
Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein Frontiers in Microbiology
K. Djawe (2010)
European Centre for Disease Prevention and Control.
Roger John Evans (2014)
Immunochromatographic assay for serodiagnosis of tuberculosis using an antigen–colloidal gold conjugate
Dmitriy V. Sotnikov (2015)
The use of gold nanoparticles in diagnostics and detection.
Robert Wilson (2008)
Serologic Responses to Recombinant Pneumocystis jirovecii Major Surface Glycoprotein among Ugandan Patients with Respiratory Symptoms
Robert J Blount (2012)
Pneumocystis Pneumonia in HIV-positive Adults, Malawi1
Joep J G van Oosterhout (2007)
Nanoparticles in molecular diagnostics.
Pedro Viana Baptista (2011)
Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers.
Fernando Esteves (2015)
Unravelling Malaria Antigen Binding to Antibody-Gold Nanoparticle Conjugates
Miguel A Cavadas (2016)
Controlled adsorption of cytochrome c to nanostructured gold surfaces
Inês Gomes (2012)
HIV-associated Pneumocystis pneumonia.
Laurence Huang (2011)
Pneumocystis jirovecii (今月の特集 深在性真菌症を学ぶ)
藤井 毅 (2014)
Gold nanoparticles in analytical chemistry
Miguel Valcârcel Cases (2014)
Laboratory diagnosis of Pneumocystis jirovecii pneumonia
Olga Matos (2016)
Is the unique camouflage strategy of Pneumocystis associated with its particular niche within host lungs?
Philippe M Hauser (2019)
Pneumocystis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya.
Jeremiah Muhwa Chakaya (2003)
Pneumocystis jirovecii in General Population
Francisco Javier Medrano (2005)
Colonization by Pneumocystis jirovecii and Its Role in Disease
Alison M Morris (2012)
Gold magnetic nanoparticle conjugate-based lateral flow assay for the detection of IgM class antibodies related to TORCH infections.
Xingxing Li (2015)
Determination of size and concentration of gold nanoparticles from UV-vis spectra.
Wolfgang Haiss (2007)
In situ Characterization of Nanoparticles Using Rayleigh Scattering
Biswajit Santra (2017)
Nanogold based lateral flow assay
J. srep40230 Singh (2015)
Theoretical and Experimental Comparison of Different Formats of Immunochromatographic Serodiagnostics
Dmitriy V. Sotnikov (2018)
Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients.
Ann E. Wakefield (2003)
Colonization by Pneumocystis jirovecii
K. A. Norris (2012)
Gel electrophoretic analysis
Cushion New York (2016)
Passive Intranasal Monoclonal Antibody Prophylaxis against Murine Pneumocystis carinii Pneumonia
Francis Gigliotti (2002)
Genetics of Surface Antigen Expression inPneumocystis carinii
James R. Stringer (2001)
Gel electrophoretic analysis of differently shaped interacting and non-interacting bioconjugated nanoparticles
Suhee Kim (2016)
Pneumocystis jirovecii Pneumonia in Africa: Impact and Implications of Highly Sensitive Diagnostic Technologies
Olga Matos (2012)
Measurement of adsorption constants of laccase on gold nanoparticles to evaluate the enhancement in enzyme activity of adsorbed laccase.
Miguel Peixoto de Almeida (2018)
Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients.
Antoine Roux (2014)
Evaluation of a modified lateral flow immunoassay for detection of high-sensitivity cardiac troponin I and myoglobin.
Jimin Zhu (2013)
Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina
Rekha R. Rapaka (2010)
Gold nanoparticles and proteins, interaction,
R. Franco (2013)
A lateral flow assay
C. 108-J Pöhlmann (2014)
Serum Antibody Levels to the Pneumocystis jirovecii Major Surface Glycoprotein in the Diagnosis of P. jirovecii Pneumonia in HIV+ Patients
Kpandja Djawe (2010)
A modified method for obtaining large amounts of high titer polyclonal ascites fluid.
S K Ou (1993)
Pneumocystis Pneumonitis in Non-HIV-Infected Patients: Update
Walter Hughes (2004)
Pneumocystis pneumonia in South African children diagnosed by molecular methods
Brenda M Morrow (2012)
Kinetically controlled seeded growth synthesis of citrate-stabilized gold nanoparticles of up to 200 nm: size focusing versus Ostwald ripening.
Neus G. Bastús (2011)
Gold nanoparticle-based fluorescence immunoassay for malaria antigen detection
Bassem Samy Guirgis (2011)
Gold nanoparticle-based novel enhancement method for the development of highly sensitive immunochromatographic test strips
Naoki Nagatani (2006)
Serologic responses to Pneumocystis proteins in human immunodeficiency virus patients with and without Pneumocystis jirovecii pneumonia
M. R. Gingo (2011)
次世代燃料電池触媒開発のための in situ characterization
康裕 岩澤 (2011)
Pneumocystis jirovecii Pneumonia:: Current Advances in Laboratory Diagnosis
Ana Luísa Tomás (2018)
Gold nanoparticles and proteins, interaction,
R. Franco (2013)
Gold nanoparticles for the development of clinical diagnosis methods
Pedro Viana Baptista (2008)
Quantities and units for electrophoresis in the clinical laboratory (IUPAC Recommendations 1994)
Georges Férard (1994)
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.
Alexandre Alanio (2016)
Laboratory diagnosis of Pneumocystis jirovecii
O. 486–487. Matos (2016)
Evidence-based point-of-care diagnostics: current status and emerging technologies.
Cangel Pui Yee Chan (2013)
Lateral Flow Immunoassay Systems: Evolution from the Current State of the Art to the Next Generation of Highly Sensitive, Quantitative Rapid Assays
Brendan O'farrell (2013)
Pneumocystis carinii pneumonia: a review of current issues in diagnosis and management.
Simon M Barry (2001)
Pneumocystis and Pneumocystosis: first meeting of experts from Latin-American and Portuguese-speaking countries – a mini-review
Francisco Esteves (2014)
Vaccine-Induced Immunogenicity and Protection Against Pneumocystis Pneumonia in a Nonhuman Primate Model of HIV and Pneumocystis Coinfection.
Heather M. Kling (2016)
Genetic characterization of the UCS and Kex1 loci of Pneumocystis jirovecii
Ferreira Esteves (2008)
Serological diagnosis of pneumocystosis: production of a synthetic recombinant antigen for immunodetection of Pneumocystis jirovecii
Ana Laura Tomás (2016)
Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jirovecii
K. R. Daly (2004)
Pneumocystis jirovecii and Pneumocystosis
Olga Matos (2017)
A lateral flow assay for identification of Escherichia coli by ribosomal RNA hybridisation.
Christopher Pöhlmann (2014)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar